INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

26,614 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$485K
3,186 sh
Nov 13, 2025
Page 648 of 666
← PrevNext →
Nov 14, 2025
traded Nov 13, 2025
+1d
SEC Form 4

Evidence

18
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$179K
553 sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

16
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$136K
868 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$100K
650 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$237K
1,536 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$198K
1,276 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$198K
1,276 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$237K
1,535 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$100K
650 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

16
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$135K
867 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

14
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$1.55M
3,406 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

14
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$1.11M
2,420 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

13
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$24K
150 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

13
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$24K
150 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

12
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
10.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

12
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Open-market sale · 10b5-1 plan
SELL$246K
8,421 sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

12
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
10.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$891K
1,960 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$319K
711 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$276K
604 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$547K
1,210 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$566K
1,255 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$485K
1,069 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$958K
2,132 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

11
ND
Nguyen DianeEVP, Chief Legal Officer & GC
QBTSD-Wave Quantum Inc.
Open-market sale · 10b5-1 plan
SELL$473K
20.0K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

10
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$35K
400 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

9
KZ
Katz ZacharyGC and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$198K
13.8K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

8
ND
Nguyen DianeEVP, Chief Legal Officer & GC
QBTSD-Wave Quantum Inc.
Open-market sale · 10b5-1 plan
SELL$65K
2,803 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

8
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$204K
453 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

8
MH
Meyer Andrew HollmanChief Business Officer
JANXJanux Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$100K
3,333 sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

8
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$197K
430 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

5
CL
Charlton Rebecca LSVP, Controller & CAO
BKRBaker Hughes Co
Open-market sale · 10b5-1 plan
SELL$13K
278 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

5
SD
Sroka DianaDirector
SOUNSOUNDHOUND AI, INC.
Open-market sale · 10b5-1 plan
SELL$17K
1,343 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

5
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
882 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$769K
1,702 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$293K
654 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$400K
881 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$1000K
2,218 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$913K
30.0K sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$724K
1,599 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence